Transfusion-transmitted malaria: donor prevalence of parasitaemia and a survey of healthcare workers knowledge and practices in a district hospital in Ghana by Alex Owusu-Ofori et al.
Owusu‑Ofori et al. Malar J  (2016) 15:234 
DOI 10.1186/s12936‑016‑1289‑3
RESEARCH
Transfusion‑transmitted malaria: donor 
prevalence of parasitaemia and a survey 
of healthcare workers knowledge and practices 
in a district hospital in Ghana
Alex Owusu‑Ofori1,2*, Dominic Gadzo3 and Imelda Bates4
Abstract 
Background: Transfusion‑transmitted malaria (TTM) is a risk of transfusion that has not been well described in 
malaria endemic regions. The risk of the recipient getting malaria is related to the prevalence of malaria in the blood 
donors. There is however little information on the prevalence of malaria among donors in Akatsi district of Ghana. Fur‑
ther, the knowledge and practices of healthcare workers to TTM is unknown. The study was undertaken to determine 
the prevalence of malaria parasite infection among blood donors and to evaluate the knowledge and practices of 
healthcare workers to TTM in the Akatsi district of Ghana.
Methods: The study was conducted at Akatsi South District Hospital between May and August 2014. To screen for 
Plasmodium falciparum, 5 µl of capillary blood was obtained by finger prick from 200 participants (100 donors and 100 
healthy controls). Plasmodium falciparum screening was done using CareStart™ Malaria Antigen kit. To obtain informa‑
tion regarding TTM knowledge and practices, questionnaires were completed by 100 health workers including nurses, 
doctors and laboratory staff.
Results: The prevalence of P. falciparum was the same (10 %) in both donors and controls. All those who were malaria 
RDT positive were aged 15–25 years. Out of the 100 healthcare workers (31 males and 69 females) surveyed, 45 % 
of respondents (45/100) had never heard of transfusion‑transmitted malaria. Almost all respondents (91 %) had not 
attended any lecture/seminar/workshop on blood transfusion in the past 12 months. There were 44 respondents 
(44 %) who wrongly said malaria was being screened for prior to transfusion in their hospital. However, 98.2 % (54/55) 
of those who had heard about TTM rightly stated that TTM can be prevented.
Conclusion: The prevalence of P. falciparum parasitaemia is 10 % in healthy blood donors in the Akatsi district and 
represents a risk for TTM though the extent of this risk is unclear. Knowledge about TTM in healthcare workers in the 
district is low. Continuous education and in‑service training may be a means to improve TTM knowledge and preven‑
tive practices by the health workers in the district.
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Background
The global burden of malaria has been considerably 
reduced over recent years [1]. However malaria still 
remains a major cause of morbidity and mortality [2]. In 
2015, the estimated number of malaria cases in Africa 
was 218 million out of which were 395,000 deaths 
[3]. The gains made in malaria may in part be attrib-
uted to the coherent way in which scientists and public 
health workers have cooperated together. This has been 
done by developing integrated control and elimination 
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programmes tailored for specific endemic settings and 
an active engagement in the research and development 
agenda required for malaria eradication [4].
Since the first reported case of transfusion-transmitted 
malaria (TTM) in 1911 [5], transfusion has been recog-
nized as a well known source for malaria transmission. 
In non-endemic countries, TTM has been well described 
and can cause serious illness in non-immune recipients 
so measures have been put in place to prevent its occur-
rence. Potential blood donors who have visited malaria 
endemic regions are not allowed to donate blood for a 
specific period depending on the policy of that country 
and this can range from 6 months to several years. How-
ever in malaria endemic countries, the burden of TTM 
and its contribution to the overall burden of malaria is 
unknown. The prevalence of Plasmodium parasitaemia 
in blood donors varies depending on the endemicity of 
malaria in the region they live. In Africa, prevalence was 
found to range between 0.7–55 % [6]. These blood donors 
are a potential risk for TTM. From the few published 
studies on the incidence of TTM in malaria endemic 
countries it is clear that not all recipients of malaria-
positive blood develop TTM and, because of the high 
endemicity some may develop malaria post-transfusion 
unrelated to the transfusion [7, 8].
Screening healthy donors for malaria in endemic 
countries poses a diagnostic challenge. This is because 
currently there is no screening test that is practical, 
affordable and suitably sensitive for blood banks [9]. 
Microscopy, which is the gold standard and is most fre-
quently used, is not a sufficiently sensitive test especially 
when parasite density is low. Microscopy is time consum-
ing and cannot realistically be used on a large scale as a 
screening tool in blood banks. Malaria rapid diagnos-
tic tests (RDTs) are increasingly being used in malaria 
endemic settings and are useful for complying with the 
WHO strategy of confirming diagnosis before treatment. 
RDTS are simple to use, and may now be superior or 
equal in diagnostic sensitivity for uncomplicated Plasmo-
dium falciparum malaria [10]. They have not been widely 
evaluated as a screening tool in blood donors.
The knowledge of health workers about TTM has not 
been previously evaluated. There is very little published 
data relating to practices and attitudes of health workers 
to TTM. A study found that practices in a teaching hos-
pital are related to particular departments where doctors 
worked [11].
The aim of this study was to determine the prevalence 
of malaria in blood donors by RDT, compared to con-
trols. In addition the knowledge, attitudes and practices 
of health workers in the district hospital in relation to 
transfusion malaria was determined.
Methods
Study site
The study was carried out in the Akatsi District Hospi-
tal (ADH), a public healthcare facility in the Akatsi South 
District of the Volta region of Ghana. ADH has staff 
strength of 140 healthcare workers including two doc-
tors, a medical assistant, a pharmacist and a biomedi-
cal scientist. ADH is a 70-bed capacity, with a maternity 
unit, medical laboratory unit, family planning unit and an 
outpatient department. It also acts as referral centre for 
the surrounding primary health facilities in the district. 
Approximately 450 blood transfusions are carried out 
each year in ADH. Blood donations are from both volun-
tary and family replacement donors. The hospital blood 
bank routinely screens donor blood for hepatitis B, hepa-
titis C, HIV and syphilis.
Enrolment
Blood donors and healthy controls from the community 
formed the study population to determine prevalence of 
malaria and health workers in ADH were the study popu-
lation for the survey conducted. Donors who were aged 
between 15–55 years, had an haemoglobin (Hb) of more 
than 12.5  g/dL and were Hepatitis B, Hepatitis C, HIV, 
and syphilis negative were eligible for enrolment. These 
donors were consecutively enrolled after obtaining their 
written informed consent.
Healthy controls were also consecutively enrolled from 
individuals accompanying their relatives to the hospital, 
people working in the hospital or living in and around 
the hospital. Participants were excluded from the study 
if they show any sign of malaria, had fever or had been 
treated for malaria 4  weeks prior to enrolment. For the 
health worker survey, the study population was recruited 
from all health workers of ADH. A list of the names of 
all 142 health workers in ADH was obtained from the 
staff office. Workers were then approached individu-
ally to obtain their consent to participate in the study. 
Workers who gave their consent were given the study 
questionnaire to completely fill out. It was pretested and 
subsequently modified into a four-part document with a 
socio-demographics section, a knowledge section and a 
section on attitudes and practices. Responses to a total of 
40 open and closed ended questions were anonymous so 
as to obtain frank answers without fear of victimization. 
The study questionnaire used was adapted and modified 
from a previously reported model [12].
Health workers were given 24 h to complete the ques-
tionnaire. Those who did not submit were reminded by 
phone or followed up in person. In total, 120 question-
naires were systematically distributed but 100 were 
returned for data entry and analysis.
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Malaria RDT testing
In total, blood samples were taken from 200 subjects, 100 
blood donors and 100 controls.
Five microlitres of capillary blood sample was obtained 
from each donor and control participant for malaria 
parasite screening. Samples were collected at the start of 
the rainy season, between May and July 2014. This period 
represents the start of the malaria transmission season. 
Malaria testing was performed using CareStart™ Malaria 
Antigen test kit (Access Bio, Inc., USA); a histidine-rich 
protein (HRP-2) based rapid diagnostic tests (RDT) that 
detects P. falciparum. The use of this rapid kit has been 
previously been reported [13].
Data analysis
Data collection was by paper case report sheets. Data 
were entered electronically and analysed using Statistical 
Package for Social Sciences (SPSS) for Windows (version 
17.0). Prevalence of malaria, determined by malaria RDT 
positivity in donors and controls was calculated by divid-
ing the number of positive results by the total number of 
samples.
Ethical approval
Approval for this study was given by the Committee on 
Human Research Publication and Ethics of the School of 
Medical Sciences, Kwame Nkrumah University of Sci-
ence and Technology in Kumasi, Ghana and the Manage-
ment of Akatsi District Hospital in the Volta Region of 
Ghana. Study participants were assured of confidentiality 
and all data collected remained anonymous.
Results
Donor and control groups were comparable in gender 
and age distribution. Males made up the majority in both 
groups; 55.0 % of donors and 57.0 % of controls respec-
tively (Table  1). Those aged 15–25  years made up the 
majority and those above 46 years were the least in both 
groups (Table  1). The prevalence of P. falciparum was 
found to be 10 % in both donors and controls (Table 1). 
All those with positive malaria RDT malaria were aged 
15–25 years. Males had a higher prevalence (10.9 %, 95 % 
CI 2.7–19.1 %) than females (8.9 %, 95 % CI 0.6–17.2 %) 
in donors. Similarly among controls, prevalence in males 
(14.0 %, 95 % CI 5.0–23.1 %) was higher than in females 
(4.7  %, 95  % CI 2.7–19.1  %) although the differences 
between males and females were not significant.
Survey
The majority of the respondents to the question-
naire were females (69.0  %) and were aged between 
20–30  years old (77.0  %). The most common job cat-
egories were nurses and nursing students followed by 
laboratory technicians (Table 2). Those who had worked 
less than 5  years made up 74.0  % of respondents and 
formed the majority. Ten percent of respondents had 
worked for more than 15 years in the hospital (Table 2).
Health workers knowledge about TTM
Only 9.0 % of health workers had attended a seminar or 
workshop on blood transfusion in the past 12  months 
(Table  3). More than half, 55 out of 100 respondents 
(55.0 %) said they knew about TTM. The others had not 
heard of TTM. Of the 55 respondents who knew about 
TTM, 30 (54.5  %), the majority being nurses, regarded 
TTM as a major public health threat in Ghana (Table 3). 
Of the respondents that knew about TTM, 52/55 (94.5 %) 
thought that screening blood donors for malaria was 
necessary in Ghana. Regarding persons at risk of TTM 
in Ghana, although the majority, 27/55 of respondents 
(49.1 %) thought everyone was equally at risk for TTM, 
the rest thought that children under 5  years, pregnant 
women and people living with HIV/AIDS were particu-
larly at-risk (Table 3).
There were 54 out of 55 respondents (98.2 %) who cor-
rectly knew that TTM is a preventable disease. Almost 
all respondents 89.1 % correctly mentioned screening of 
donated blood before donation as a prevention measure 
(Table 3). Only one out of 55 respondents (1.8 %) iden-
tified “treating transfusion recipients” as a prevention 
measure for TTM but 52.7  % agreed that transfusion 
recipients could be given anti-malarials as prophylaxis. 
The majority of respondents, 37 out of 55 (67 %) however 
agreed that routine use of anti-malarials in all transfusion 
recipients’ patients may lead to anti-malarial misuse and 
promote the spread of drug resistance (Table 3).
Health workers’ attitudes and practices
Fifty percent of respondents (50/100) were directly 
involved with blood transfusion in Akatsi district 
Table 1 Demographics and  prevalence rate of  Plasmo-
dium prevalence rate in donors and non donors





 Males 55 (55.0) 57 (57.0)
 Females 45 (45.0) 43 (43.0)
Age groups (years)
 15–25 79 (79.0) 55 (55.0)
 26–35 12 (12.0) 35 (35.0)
 36–45 8 (8.0) 7 (7.0)
 >46 1 (1.0) 3 (7.0)
Prevalence rate 10 (10.0) 10 (10.0)
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hospital. Blood administration (41.0  %) and transfusion 
monitoring (30.0  %) were the most common activities 
while donor recruitment (3.0 %) and blood prescription 
(4.0 %) were the least common transfusion practices that 
staffs of ADH were involved in (Table 4).
The majority of the respondents (44.0  %) wrongly 
stated that the hospital blood bank was screening for 
malaria parasite in blood donors before blood donation 
while a quarter of respondents were not sure if screening 
was being done or not (Table 4).
Among the 55 respondents who knew about TTM, 30 
(54.5  %) indicated their willingness to transfuse malaria 
positive blood when faced with an emergency situation. 
In contrast, none of the 55 respondents were willing to 
transfuse hepatitis B positive blood in case of an emer-
gency. The majority of the respondents 92.7  % (51/55) 
also indicated that they were unwilling to transfuse 
syphilis positive blood in a case of emergency (Table 4). 
Based on their current knowledge, 67.3 % of the workers 
(37/55) would not routinely give anti-malarials to trans-
fusion recipients. A small proportion, 2/55 (3.6 %) would 
routinely give anti-malarials only to children receiving a 
transfusion, while 29.1 % would give anti-malarials rou-
tinely to every transfusion recipient (Table 4).
Discussion
TTM in malaria endemic countries is attracting increas-
ing attention with the current drive to reduce all avenues 
of transmission. TTM had been a neglected area of trans-
fusion but since a meeting in Mombasa, Kenya identified 
TTM as a key gap in transfusion research in 2008 [14], 
there have been at least three major review articles and 
several other publications on different aspects of TTM.
This study showed that the prevalence of P. falcipa-
rum malaria in donors by RDT method was 10  %. This 
was similar to the findings from a study carried out in 
Kumasi, Ghana where P. falciparum prevalence was 
13.7 % in donors by RDT [8]. Other African studies have 
found malaria prevalence in blood donors to be as high 
as 50 % [6]. The presence of parasitaemia in blood donors 
represents a potential risk to transfusion recipients and 
can result in TTM occurring in up to 28 % of recipients 
[7]. Certain factors such as refrigeration of blood at 4 °C 
and the immunity of the recipient may affect the suscep-
tibility of individual recipients. Currently most blood 
banks in malaria-endemic African countries are not rou-
tinely screening blood for malaria. Ethical questions have 
been raised concerning whether it is appropriate to reject 
parasitaemic blood donors in malaria endemic countries 
where blood supplies are inadequate and the risks of clin-
ically important TTM have not been well documented. 
Rejecting such donors will exacerbate already critical 
blood shortages and have the potential to increase mor-
tality. Malaria RDTs may have a high rate of false posi-
tives test because of the presence of circulating antigens 
even after treatment. In recent times however, the role 
of malaria RDT testing cannot be disputed. RDT use has 
expanded greatly due to the WHO treatment guidelines 
which recommend the confirmation of parasitaemia prior 
to treatment with ACT [15]. The sensitivity of the RDTs 
has also been greatly improved and together with micros-
copy, they represent the best hope for accurate diagnosis 
as a key component of successful malaria control [16]. 
This study found the prevalence of P. falciparum malaria 
in donors and their controls to be the same (10 %). This is 
not surprising and is an indication that the blood donors 
are a true representation of the healthy adult population 
in the district. In many African countries the donor pop-
ulation is usually male dominated. However in this study, 
females were almost half of all donors. In this study, it is 
unclear why the prevalence of parasitaemia in males was 
more than double that of females in the control group. 
Some studies have established that parasitaemia is not 
significantly associated with the gender of donors. Ukaga 
et al. [17] found prevalence rates of 22.5 and 25.4 % for 
males and females respectively in Owerri, Nigeria.
The survey results showed that only 9 % of the respond-
ents had attended any workshop on blood transfusion in 
Table 2 Socio-professional characteristics of  participants 
in the health worker survey
Characteristics Number (%)
Gender
 Male 31 (31.0)
 Female 69 (69.0)
Age (years)
 20–30 77 (77.0)
 31–40 11 (11.0)
 41–50 5 (5.0)
 51–60 7 (7.0)
Job category
 Nurse 63 (63.0)
 Nursing student 16 (16.0)
 Lab technician 6 (6.0)
 Lab assistant 2 (2.0)
 Doctors 2 (2.0)
 Pharmacist technician 2 (2.0)
 Pharmacists 1 (1.0)
 Biomedical scientist 1 (1.0)
 Others 7 (7.0)
Period of working life (years)
 <5 74 (74.0)
 5–10 14 (14.0)
 11–15 2 (2.0)
 >15 10 (10.0)
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the past 12 months. In Ghana, professional bodies require 
continuous professional development while health insti-
tutions encourage service training in all aspect of medi-
cine. In many high-income countries, regular training 
on blood transfusion is mandatory, reflecting the impor-
tance of transfusion for patient safety and treatment. 
Much more advocacy is needed by the health professions 
and blood services in Ghana to ensure that transfusion is 
included in undergraduate curricula and in-service train-
ing programmes.
Knowledge about TTM was generally low among health 
workers in Akatsi. Almost half of the health workers had 
not heard about TTM. Malaria has been neglected a 
transfusion-transmitted infection, having been substan-
tially overshadowed predominantly by a focus on HIV. 
Almost all respondents wrongly assumed that screening 
for malaria was being performed in Ghana. It is likely 
that the workers assumed that because routine screen-
ing takes place for HIV and hepatitis, malaria screening 
also takes place. It is unclear why a quarter of respond-
ents admitted they were not sure if screening was done in 
their hospital but did not say so when questioned about 
screening across Ghana. If this level of misinformation 
occurs across Ghana then there is a clear need to pro-
vide education on TTM and particularly around strate-
gies that can be used to reduce transmission through 
transfusion and to correct some assumptions that may 
negatively affect practice. It is interesting to observe that 
many health workers were unwilling to transfuse hepati-
tis B or syphilis positive blood but many were willing to 
transfuse malaria positive blood. Further investigations 
to determine the rationale for this will be useful.
Nearly all respondents (89.1  %) knew the most effec-
tive way of preventing TTM. This high level of knowledge 
could be possibly due to the effective malaria campaigns 
going on across the country. However, a third of health 
workers did not think that routine use of anti-malarials in 
transfusion will ultimately contribute to the spread of drug 
resistance. Current World Health Organization policies 
and treatment guidelines recommend that parasitologi-
cal confirmation of malaria should be done before initiat-
ing the treatment [18]. However this advice is difficult to 
interpret in the context of blood transfusion and contra-
dicts other guidelines [19] which advise that all transfusion 
Table 3 Health worker knowledge about transfusion-transmitted malaria
Question Number  
of respondents
Answer Number (%)
In the past 12 months have you attended a seminar/workshop on blood 
transfusion
100 Yes 9 (9.0)
No 91 (91.0)
Have you heard of TTM? 100 Yes 55 (55.0)
No 45 (45)
Is TTM a major public health threat in Ghana? 55 Yes 30 (54.5)
No 11 (20.0)
Not sure 14 (25.5)
Is malaria screening before blood donation necessary in Ghana? 55 Yes 52 (94.5)
No 3 (5.5)
Who are the most at‑risk group for TTM? 55 Everyone 27 (49.1)
Children <5 years (A) 5 (9.1)
Pregnant women (B) 2 (3.6)
HIV/AIDS patients (C) 1 (1.8)
A and B 5 (9.1)
A and B and C 15 (27.3)
Can TTM be prevented? 55 Yes 54 (98.2)
No 1 (1.8)
How can TTM be prevented? 55 Screening of donor blood 49 (89.1)
Using mosquito nets 3 (5.5)
Treating transfusion recipients 1 (1.8)
Not sure 2 (3.6)
Do you agree with proposals for all transfusion recipient to be given anti‑
malarials
55 Yes 29 (52.7)
No 26 (47.3)
Will routine use of anti‑malarials lead to abuse and spread of drug  
resistance?
55 Yes 37 (67.3)
No 18 (32.7)
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recipients should receive anti-malarials. It is not surprising 
that this confusing guidance translates into lack of consist-
ency in the prevention of TTM in clinical practice [11].
TTM is a ‘hidden’, neglected and under researched 
reservoir of ongoing malaria transmission. The recent 
announcement of a new one billion dollar fund to elimi-
nate malaria means that renewed efforts are needed to 
understand and reduce the risks of malaria [20] transmis-
sion through blood transfusion.
Conclusions
Healthy blood donors at the Akatsi district hospital have 
a 10  % prevalence rate of P. falciparum parasitaemia. 
This represents a potential risk for transmitting malaria 
via transfusion. While knowledge about TTM among 
healthcare workers in the district is low, continues educa-
tion and in-service training may be a means to improve 
knowledge and preventive practices by the health work-
ers in the district.
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